Phase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated Squamous Cell Carcinoma

Conditions:   Cancer;   Carcinoma;   Squamous Cell Carcinoma;   Head and Neck Cancer
Interventions:   Biological: Atezolizumab;   Biological: Emactuzumab
Sponsors:   University of California, San Francisco;   Genentech, Inc.
Not yet recruiting

https://ift.tt/2yFYSsK